UNITY Biotechnology (UBX) announced topline results from the Phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic macular edema who had poor vision despite prior anti ...
PDS Biotechnology (PDSB) announced the initiation of the VERSATILE-003 Phase 3 clinical trial. The trial is now open to patient enrollment. VERSATILE-003 is a global, multi-center, randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback